n-(2-(diethylamino)ethyl)-4-iodobenzamide has been researched along with Sensitivity and Specificity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacin, F; Bonafous, J; Chossat, F; D'Incan, M; Kemeny, JL; Mestas, D; Moins, N; Sillaire-Houtmann, I; Veyre, A | 1 |
| Bacin, FJ; Bonafous, JF; Bussiere, F; Chossat, FM; Madelmont, JC; Mauclaire, LP; Michelot, JM; Moreau, MF; Souteyrand, PA; Veyre, AJ | 1 |
| Bossuyt, A; Everaert, H; Flamen, P; Franken, PR; Mertens, J | 1 |
| Labarre, P; Madelmont, JC; Moreau, MF; Papon, J; Veyre, A | 1 |
| Bacin, F; Bekhechi, D; Bonafous, J; Chossat, F; Kemeny, JL; Michelot, J; Moreau, MF; Veyre, A | 1 |
| Brandau, W; Coenen, HH; Dittmann, H; Dutschka, K; Streffer, C; Zölzer, F | 1 |
3 trial(s) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and Sensitivity and Specificity
| Article | Year |
|---|---|
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Topics: Benzamides; Choroid Neoplasms; Ciliary Body; Conjunctival Neoplasms; Diagnosis, Differential; Eye Neoplasms; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Melanoma; Ophthalmoscopy; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Uveal Neoplasms | 2004 |
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Sensitivity and Specificity | 1993 |
Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Brachytherapy; Conjunctival Neoplasms; Contrast Media; Eye Enucleation; Female; Humans; Laser Coagulation; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Uveal Neoplasms | 1998 |
3 other study(ies) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and Sensitivity and Specificity
| Article | Year |
|---|---|
Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
Topics: Benzamides; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Nevus; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Uveal Neoplasms | 1997 |
A new quantitative method to evaluate the biodistribution of a radiolabelled tracer for melanoma using whole-body cryosectioning and a gaseous detector: comparison with conventional tissue combustion technology.
Topics: Animals; Benzamides; Carbon Radioisotopes; Contrast Media; Cryoultramicrotomy; Image Processing, Computer-Assisted; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Radionuclide Imaging; Rats; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole-Body Counting | 1998 |
In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA).
Topics: Benzamides; Iodine Radioisotopes; Iodobenzoates; Melanins; Melanoma; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals; Receptors, sigma; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |